Literature DB >> 3742721

Sulfamate formation is a major route for detoxification of 2-amino-3-methylimidazo[4,5-f]quinoline in the rat.

R J Turesky, P L Skipper, S R Tannenbaum, B Coles, B Ketterer.   

Abstract

The major biliary metabolite of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in the rat was identified as the sulfamate derivative, N-[3-methylimidazo[4,5-f]quinolin-2-yl] sulfamic acid. Identification was accomplished primarily by u.v., 1H-n.m.r. and mass spectrometry of the material isolated from bile and confirmed by comparison with material synthesized by reaction of chlorosulfonic acid with IQ. The sulfamate was shown to be non-mutagenic in bacterial forward mutation assays. Greater than 20% of an administered dose of IQ could be recovered from feces (17%) and urine (5%) as the sulfamate. Very little unmetabolized IQ was recovered in bile, urine, or feces. Thus, the unusual process of N-sulfation is a major contributor to the detoxification and elimination of IQ in the rat.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742721     DOI: 10.1093/carcin/7.9.1483

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

Review 1.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

2.  Characterization of new metabolites from in vivo biotransformation of 2-amino-3-methylimidazo[4,5-f]quinoline in mouse by mass spectrometry.

Authors:  Fong-Fu Hsu; Vijaya M Lakshmi; Terry V Zenser
Journal:  J Mass Spectrom       Date:  2009-09       Impact factor: 1.982

3.  N-Demethylation is a major route of 2-amino-3-methylimidazo[4,5-f]quinoline metabolism in mouse.

Authors:  Vijaya M Lakshmi; Fong Fu Hsu; Terry V Zenser
Journal:  Drug Metab Dispos       Date:  2008-03-20       Impact factor: 3.922

4.  Identification of new 2-amino-3-methylimidazo[4,5-f]quinoline urinary metabolites from beta-naphthoflavone-treated mice.

Authors:  Vijaya M Lakshmi; Fong-Fu Hsu; Terry V Zenser
Journal:  Drug Metab Dispos       Date:  2009-05-18       Impact factor: 3.922

5.  Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b] pyridine by cDNA-expressed human and rat arylsulfotransferases.

Authors:  S Ozawa; H C Chou; F F Kadlubar; K Nagata; Y Yamazoe; R Kato
Journal:  Jpn J Cancer Res       Date:  1994-12

Review 6.  Metabolism and biomarkers of heterocyclic aromatic amines in humans.

Authors:  Medjda Bellamri; Scott J Walmsley; Robert J Turesky
Journal:  Genes Environ       Date:  2021-07-16

7.  Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring.

Authors:  R J Turesky; G A Gross; W G Stillwell; P L Skipper; S R Tannenbaum
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

8.  Characterization and expression of hepatic sulfotransferase involved in the metabolism of N-substituted aryl compounds.

Authors:  Y Yamazoe; S Ozawa; K Nagata; D W Gong; R Kato
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

9.  Formation of 2-amino-3-methylimidazo[4,5-f]quinoline- and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-sulfamates by cDNA-expressed mammalian phenol sulfotransferases.

Authors:  S Ozawa; K Nagata; Y Yamazoe; R Kato
Journal:  Jpn J Cancer Res       Date:  1995-03

10.  Comparison of XAD-2 column and blue cotton batch techniques for isolation of metabolites of 2-amino-3-methylimidazo[4,5-f]quinoline.

Authors:  T Inamasu; H J Luks; J H Weisburger
Journal:  Jpn J Cancer Res       Date:  1988-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.